1. F. Ma*, G. Lu*, Q. Chen, Y. Ruan, X. Li, X. Lu#, C. Li#, Dynamic global analysis of transcription reveals the role of miRNAs in synergistic stabilization of gene expression, Science Bulletin, 65, 2130-2140 (2020).
2. 刘倩, 李春燕, 增强子的鉴定及其在肿瘤研究中的应用, 遗传 (Hereditas), 42, 817-831 (2020)
3. T. Li*, J. Liu*, J. Feng*, Z. Liu, S. Liu, M. Zhang, Y. Zhang, Y. Hou, D. Wu, C. Li, Y. Chen, H. Chen, X. Lu#, Variation in the life history strategy underlies functional diversity of tumors, National Science Review, Online in advance (2020)
4. S. Liu*, Z. Yang*, G. Li*, C. Li, Y. Luo, Q. Gong, X. Wu, T. Li, Z. Zhang, B. Xing, X. Xu#, X. Lu#, Multi-omics analysis of primary cell culture models reveals genetic and epigenetic basis of intratumoral phenotypic diversity, Genomics Proteomics Bioinformatics 17, 576-589 (2019)
5. X. Bai*, Z. Liu*, X. Shao, D. Wang, E. Dong, Y. Wang, C. Wu, Y. Yuan, X. Lu#, C. Li#, The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma, PLoS ONE 14, e0211581 (2019).
6. H. Chen*, C. Li*, X. Peng, Z. Zhou, The Cancer Genome Atlas Research Network, J. N. Weinstein, H. Liang, A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell 173, 386-399 (2018).
7. H. Chen*, C. Li*, Z. Zhou, H. Liang, Fast-evolving human-specific neural enhancers are associated with aging-related diseases. Cell Systems 6, 604-611 (2018).
8. C. Li*, Y. Hou*, J. Xu*, A. Zhang, Z. Liu, F. Qi, Z. Yang, K. Chen, S. Liu, H. Huang, Q. Wang, J. Dong, C. Wu, X. Lu, A direct test of selection in cell populations using the diversity in gene expression within tumors. Molecular Biology and Evolution 34, 1730-1742 (2017).
9. C. Li*, Z. Liu*, F. Yang*, W. Liu, D. Wang, E. Dong, Y. Wang, C. Wu, X. Lu, siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells. Oncotarget 6, 21603-21613 (2015).
10. Y. Tao*, Z. Hu*, S. Ling*, S. Yeh, W. Zhai, K. Chen, C. Li, Y. Wang, K. Wang, H. Wang, E. A. Hungate, K. Onel, J. Liu, C. Zeng, R. R. Hudson, P. Chen, X Lu#, C. Wu#, Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics, bioRxiv 2015:025429
11. Z. Chong*, W. Zhai*, C. Li, M. Gao, Q. Gong, J. Ruan, J. Li, L. Jiang, X. Lv, E. Hungate, and C. I. Wu, The evolution of small insertions and deletions in the coding genes of Drosophila melanogaster. Molecular Biology and Evolution 30, 2699-2708 (2013).
12. J. Ruan*, L. Jiang*, Z. Chong*, Q. Gong*, H. Li, C. Li, Y. Tao, C. Zheng, W. Zhai, D. Turissini, C. H. Cannon, X. Lu#, C. I. Wu#, Pseudo-Sanger sequencing: massively parallel production of long and near error-free reads using NGS technology. BMC Genomics 14, 711 (2013).
13. Y. Tao*, J. Ruan*, S. H. Yeh*, X. Lu*, Y. Wang*, W. Zhai*, J. Cai*, S. Ling, Q. Gong, Z. Chong, Z. Qu, Q. Li, J. Liu, J. Yang, C. Zheng, C. Zeng, H. Y. Wang, J. Zhang, S. H. Wang, L. Hao, L. Dong, W. Li, M. Sun, W. Zou, C. Yu, C. Li, G. Liu, L. Jiang, J. Xu, H. Huang, C. Li, S. Mi, B. Zhang, B. Chen, W. Zhao, S. Hu, S. M. Zhuang, Y. Shen, S. Shi, C. Brown, K. P. White, D. S. Chen#, P. J. Chen, C. I. Wu#, Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proceedings of the National Academy of Sciences of the United States of America 108, 12042-12047 (2011).
14. X. Lu*, J. A. Shapiro*, C. T. Ting, Y. Li, C. Li, J. Xu, H. Huang, Y. J. Cheng, A. J. Greenberg, S. H. Li, M. L. Wu, Y. Shen, C. I. Wu, Genome-wide misexpression of X-linked versus autosomal genes associated with hybrid male sterility. Genome Research 20, 1097-1102 (2010).
15. C. Li, Z. Guo, Z. Wang, TGFß receptor saxophone non-autonomously regulates germline proliferation in a Smox/dSmad2-dependent manner in Drosophila testis. Developmental Biology 309, 70-77 (2007).
* These authors contribute equally
# corresponding authors
承担科研项目：
1. 国家自然科学基金-面上项目，促进成骨细胞分化的增强子对抗骨质疏松症的效应和机制研究，2021/01 – 2024/12，在研，主持
2. 国家自然科学基金-青年科学基金项目，利用CRISPR-cas9系统筛选和解析与癌症发生发展相关的增强子 ，2019/01 – 2021/12，在研，主持
3. 科技部国家重大科学研究计划项目，肿瘤异质性的分子网络研究和新治疗策略，2014/01 – 2018/08，结项，课题骨干
4. 科技部863计划项目，肿瘤的个体化RNA干扰治疗，2012/11 – 2015/12，结项，课题骨干
专利:
1. 李春燕、刘倩、张永彪、刘超，一种可用于抑制肿瘤增殖的非编码基因及其应用，202010361001.4（实质审查阶段）。
2. 李春燕、董恩成、刘珍珍、吕雪梅、吴仲义，筛选肿瘤早期诊断靶标的Small RNA-Seq库的构建方法，ZL201210041472.2。
3. 李春燕、杨芳、刘稳升、王瑜、吕雪梅、吴仲义，用于恶性肿瘤治疗的组合物及其应用，ZL201210046682.0。
